HARTE-HANKS INC (HHS) Stock Price, Quote, News and Overview
NASDAQ:HHS - Nasdaq - US4161962026 - Common Stock - Currency: USD
HHS Quote, Performance and Key Statistics
NASDAQ:HHS (4/30/2025, 8:11:25 PM)
5
+0.02 (+0.4%)
The current stock price of HHS is 5 USD. In the past month the price increased by 8.93%. In the past year, price decreased by -29.68%.
HHS Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TTD | TRADE DESK INC/THE -CLASS A | 32.5 | 26.36B | ||
| OMC | OMNICOM GROUP | 9.41 | 14.86B | ||
| IPG | INTERPUBLIC GROUP OF COS INC | 9.13 | 9.36B | ||
| WPP | WPP PLC-SPONSORED ADR | 6.38 | 8.32B | ||
| CRTO | CRITEO SA-SPON ADR | 7.42 | 1.85B | ||
| MGNI | MAGNITE INC | 16.99 | 1.68B | ||
| STGW | STAGWELL INC | 7.34 | 1.48B | ||
| IBTA | IBOTTA INC-CL A | 256.84 | 1.44B | ||
| LZMH | LZ TECHNOLOGY HDS LTD -CL B | N/A | 1.22B | ||
| IAS | INTEGRAL AD SCIENCE HOLDING | 30.74 | 1.16B | ||
| AMBR | AMBER INTERNATIONAL HOLDING | N/A | 880.01M | ||
| EEX | EMERALD HOLDING INC | N/A | 784.43M |
Related stock screener links
About HHS
Company Profile
Harte-Hanks, Inc. is a global customer experience company operating in three business segments: Marketing Services, Customer Care, and Fulfillment & Logistics Services. The company is headquartered in Chelmsford, Massachusetts and currently employs 1,715 full-time employees. The firm operates through four segments: Marketing Services; Customer Care, Sales Service, and Fulfillment & Logistics Services. Marketing Services segment leverages data, insight, and experience to support clients as they engage customers through digital, traditional, and emerging channels. Customer Care segment offers responsive contact center solutions, which use real-time data to interact with each customer. Customer contacts are handled through phone, e-mail, social media, text messaging, chat, and digital self-service support. Fulfillment & Logistics segment comprises mail, product fulfillment, and logistics services. The company offers a variety of product fulfillment solutions, including printing on demand, managing product recalls, and distributing literature and promotional products. The company is also a third-party logistics and freight optimization provider in the United States.
Company Info
HARTE-HANKS INC
1 Executive Drive, Suite 303
Chelmsford MASSACHUSETTS 78728 US
CEO: Andrew Benett
Employees: 1836
Company Website: https://www.hartehanks.com/
Investor Relations: http://investors.hartehanks.com/index.cfm
Phone: 15124341100
HARTE-HANKS INC / HHS FAQ
What is the stock price of HARTE-HANKS INC today?
The current stock price of HHS is 5 USD. The price increased by 0.4% in the last trading session.
What is the ticker symbol for HARTE-HANKS INC stock?
The exchange symbol of HARTE-HANKS INC is HHS and it is listed on the Nasdaq exchange.
On which exchange is HHS stock listed?
HHS stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for HARTE-HANKS INC stock?
5 analysts have analysed HHS and the average price target is 17.85 USD. This implies a price increase of 257% is expected in the next year compared to the current price of 5. Check the HARTE-HANKS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is HARTE-HANKS INC worth?
HARTE-HANKS INC (HHS) has a market capitalization of 36.85M USD. This makes HHS a Nano Cap stock.
How many employees does HARTE-HANKS INC have?
HARTE-HANKS INC (HHS) currently has 1836 employees.
What are the support and resistance levels for HARTE-HANKS INC (HHS) stock?
HARTE-HANKS INC (HHS) has a support level at 4.69 and a resistance level at 5.49. Check the full technical report for a detailed analysis of HHS support and resistance levels.
Is HARTE-HANKS INC (HHS) expected to grow?
The Revenue of HARTE-HANKS INC (HHS) is expected to grow by 4.05% in the next year. Check the estimates tab for more information on the HHS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy HARTE-HANKS INC (HHS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of HHS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of HHS, evaluating the profitability, health, valuation and growth aspects
- HARTE-HANKS INC (HHS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- HARTE-HANKS INC (HHS) Sales and EPS estimates to see what analysts future expectations are.
- HARTE-HANKS INC (HHS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- HARTE-HANKS INC (HHS) Insider and Institutional Ownership to learn about the owners and their transactions.
- HARTE-HANKS INC (HHS) Stock Chart to make your own analysis
- HARTE-HANKS INC (HHS) Latest news and press-releases to stay up to date.
Does HARTE-HANKS INC (HHS) stock pay dividends?
HHS does not pay a dividend.
When does HARTE-HANKS INC (HHS) report earnings?
HARTE-HANKS INC (HHS) will report earnings on 2025-05-08.
What is the Price/Earnings (PE) ratio of HARTE-HANKS INC (HHS)?
HARTE-HANKS INC (HHS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.17).
What is the Short Interest ratio of HARTE-HANKS INC (HHS) stock?
The outstanding short interest for HARTE-HANKS INC (HHS) is 0.62% of its float. Check the ownership tab for more information on the HHS short interest.
HHS Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to HHS. When comparing the yearly performance of all stocks, HHS is a bad performer in the overall market: 75.6% of all stocks are doing better.
HHS Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to HHS. HHS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
HHS Financial Highlights
Over the last trailing twelve months HHS reported a non-GAAP Earnings per Share(EPS) of -4.17. The EPS decreased by -1763.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -29.77% | ||
| ROE | -139.69% | ||
| Debt/Equity | 0.03 |
HHS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to HHS. The Buy consensus is the average rating of analysts ratings from 5 analysts.
For the next year, analysts expect an EPS growth of 131.2% and a revenue growth 4.05% for HHS